Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Veronica Mattiello
Observed names:
Mattiello, Veronica,
V. Mattiello
Institution:
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Observed institutions:
University of Milan,
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico,
University Hospital of Geneva
ORCID:
0000-0002-5000-1015
Observed ORCID:
0000-0002-5000-1015
OpenAlex ID:
A5036682776
Predictors of atrial fibrillation in ibrutinib-treated CLL patients: a prospective study
2018
·
Gianluigi Reda
, Bruno Fattizzo
, et al.
·
Journal of Hematology & Oncology
·
48
PDF
Epidemiology and treatment approaches in management of invasive fungal infections in hematological malignancies: Results from a single-centre study
2019
·
Nicola Stefano Fracchiolla
, Mariarita Sciumè
, et al.
·
PLoS ONE
·
36
Should treatment of hypogammaglobulinemia with immunoglobulin replacement therapy (IgRT) become standard of care in patients with chronic lymphocytic leukemia?
2023
·
Alessandro Noto
, Ramona Cassin
, et al.
·
Frontiers in Immunology
·
24
PDF
The Role of Novel Agents in Treating CLL-Associated Autoimmune Hemolytic Anemia
2021
·
Alessandro Noto
, Ramona Cassin
, et al.
·
Journal of Clinical Medicine
·
15
PDF
Obinutuzumab plus chlorambucil versus ibrutinib in previously untreated chronic lymphocytic leukemia patients without TP53 disruptions: A real-life CLL campus study
2022
·
Andrea Visentin
, Francesca Romana Mauro
, et al.
·
Frontiers in Oncology
·
14
PDF
First‐line treatment of Waldenström's macroglobulinemia in Italy: A multicenter real‐life study on 547 patients to evaluate the long‐term efficacy and tolerability of different chemoimmunotherapy strategies
2024
·
Francesco Autore
, A. Tedeschi
, et al.
·
American Journal of Hematology
·
13
Predictors of ibrutinib‐associated atrial fibrillation: 5‐year follow‐up of a prospective study
2023
·
Veronica Mattiello
, Angelica Barone
, et al.
·
Hematological Oncology
·
12
PDF
Antibody Response to the SARS-CoV-2 Vaccine and COVID-19 Vulnerability during the Omicron Pandemic in Patients with CLL: Two-Year Follow-Up of a Multicenter Study
2023
·
Francesca R. Mauro
, Diana Giannarelli
, et al.
·
Cancers
·
11
PDF
High rate of durable responses with undetectable minimal residual disease with front-line venetoclax and rituximab in young, fit patients with chronic lymphocytic leukemia and an adverse biological profile: results of the GIMEMA phase II LLC1518 – VERITAS study
2023
·
Francesca R. Mauro
, Irene Della Starza
, et al.
·
Haematologica
·
9
PDF
Ensuring continuity of care of hematologic patients during COVID-19 pandemic in a tertiary hospital in Lombardy (Italy)
2020
·
Bruno Fattizzo
, Juri Alessandro Giannotta
, et al.
·
Blood Advances
·
9
PDF
Treatment of an Acute Promyelocytic Leukemia Relapse Using Arsenic Trioxide and All-Trans-Retinoic in a 6-Year-Old Child
2014
·
Nathalie Rock
, V. Mattiello
, et al.
·
Pediatric Hematology and Oncology
·
9
Ibrutinib in patients over 80 years old with CLL: a multicenter Italian cohort
2022
·
Gianluigi Reda
, Veronica Mattiello
, et al.
·
Blood Advances
·
7
PDF
Chronic lymphocytic leukemia and prognostic models: A bridge between clinical and biological markers
2017
·
Gianluigi Reda
, Ramona Cassin
, et al.
·
American Journal of Hematology
·
7
PDF
Early detection of pulmonary hypertension in primary myelofibrosis: The role of echocardiography, cardiopulmonary exercise testing, and biomarkers
2017
·
Mariarita Sciumè
, Veronica Mattiello
, et al.
·
American Journal of Hematology
·
6
PDF
Kinetics of lymphocytosis in naïve chronic lymphocytic leukemia patients treated with covalent Bruton's tyrosine kinase inhibitors: An Italian multicenter real‐life experience
2024
·
Idanna Innocenti
, Antonio Mosca
, et al.
·
HemaSphere
·
5
PDF
Long‐term benefit of IGHV mutated patients in a real‐life multicenter cohort of FCR‐treated chronic lymphocytic leukemia
2022
·
Riccardo Moia
, Riccardo Dondolin
, et al.
·
Hematological Oncology
·
4
PDF
Lymphadenopathy as a predictor of progression during venetoclax treatment in chronic lymphocytic leukemia. A campus chronic lymphocytic leukemia study
2023
·
Francesco Autore
, Idanna Innocenti
, et al.
·
Hematological Oncology
·
2
Treatment with Venetoclax Positively Modulates Immunological Parameters and T-Cell Features in Patients with Chronic Lymphocytic Leukemia
2024
·
Valentina Griggio
, Candida Vitale
, et al.
·
Blood
·
1
PDF
36-Month Follow-up Results of the Gimema ‘Veritas’ Trial of Front-Line Venetoclax and Rituximab (VenR) in Young and Fit Patients with Chronic Lymphocytic Leukemia and an Adverse Biologic Profile
2023
·
Francesca Romana Mauro
, Irene Della Starza
, et al.
·
Blood
·
1
PDF
P659: Ibrutinib in Over-eighties Patients With Chronic Lymphocytic Leukemia: a Multicenter Italian Cohort
2022
·
G. Reda
, V. Mattiello
, et al.
·
HemaSphere
·
1
Decitabine treatment for an unusual case of atypical chronic myeloid leukemia (aCML) with a concomitant chronic lymphocytic leukemia (CLL)
2019
·
Ramona Cassin
, Veronica Mattiello
, et al.
·
Hematological Oncology
·
1
Lymphocytic variant hypereosinophilia: a challenging diagnosis of a rare disease with pleomorphic clinical picture
2018
·
Nicola Orofino
, Veronica Mattiello
, et al.
·
European Journal of Internal Medicine
·
1
Clinical Outcomes in Double‐Exposed Chronic Lymphocytic Leukemia Patients in Italy
2026
·
Francesco Autore
, Andrea Visentin
, et al.
·
Hematological Oncology
Ibrutinib or non-BTK inhibitor therapy in relapsed Waldenström macroglobulinemia: a real-life multicenter Italian study
2026
·
Francesco Autore
, Alessandra Tedeschi
, et al.
·
Blood Advances
PDF
Ibrutinib or Chemo-Immunotherapy As Second Line Treatment in Waldenstrom Macroglobulinaemia? a Real-Life Multicentre Study
2024
·
Francesco Autore
, Alessandra Tedeschi
, et al.
·
Blood
Show more works
View as search
Works count:
35
Citation count:
236
H-index:
9
I10-index:
8
Year
Topic
Type